Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Van Langenhove

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Alzheimer'S Research & Therapy|January 27, 2018
Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one familyAnne Sieben, Sara Van Mossevelde, Eline Wauters, et al.
Neurobiology of Aging|October 15, 2013
Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementiaElise Cuyvers, Karolien Bettens, Stéphanie Philtjens, et al.
European Journal of Neurology|October 24, 2024
Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN-RND)Casper Wittebrood, Marina Boban, Annchiara Cagnin, et al.
Brain : a Journal of Neurology|December 18, 2015
Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohortSara Van Mossevelde, Julie van der Zee, Ilse Gijselinck, et al.
JAMA Neurology|February 14, 2017
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat ExpansionSara Van Mossevelde, Julie van der Zee, Ilse Gijselinck, et al.
Neurobiology of Aging|April 14, 2018
Clinical variability and onset age modifiers in an extended Belgian GRN founder familyEline Wauters, Sara Van Mossevelde, Kristel Sleegers, et al.
JAMA Neurology|January 23, 2013
Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohortTim Van Langenhove, Julie van der Zee, Ilse Gijselinck, et al.
The Lancet. Neurology|December 14, 2011
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyIlse Gijselinck, Tim Van Langenhove, Julie van der Zee, et al.
Human Brain Mapping|March 10, 2023
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementiaAurélie Bussy, Jake P Levy, Tristin Best, et al.
Neurobiology of Aging|December 27, 2016
ATXN2 trinucleotide repeat length correlates with risk of ALSWilliam Sproviero, Aleksey Shatunov, Daniel Stahl, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Alzheimer'S Research & Therapy|January 27, 2018
Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one familyAnne Sieben, Sara Van Mossevelde, Eline Wauters, et al.
Neurobiology of Aging|October 15, 2013
Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementiaElise Cuyvers, Karolien Bettens, Stéphanie Philtjens, et al.
European Journal of Neurology|October 24, 2024
Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN-RND)Casper Wittebrood, Marina Boban, Annchiara Cagnin, et al.
Brain : a Journal of Neurology|December 18, 2015
Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohortSara Van Mossevelde, Julie van der Zee, Ilse Gijselinck, et al.
JAMA Neurology|February 14, 2017
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat ExpansionSara Van Mossevelde, Julie van der Zee, Ilse Gijselinck, et al.
Neurobiology of Aging|April 14, 2018
Clinical variability and onset age modifiers in an extended Belgian GRN founder familyEline Wauters, Sara Van Mossevelde, Kristel Sleegers, et al.
JAMA Neurology|January 23, 2013
Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohortTim Van Langenhove, Julie van der Zee, Ilse Gijselinck, et al.
The Lancet. Neurology|December 14, 2011
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyIlse Gijselinck, Tim Van Langenhove, Julie van der Zee, et al.
Human Brain Mapping|March 10, 2023
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementiaAurélie Bussy, Jake P Levy, Tristin Best, et al.
Neurobiology of Aging|December 27, 2016
ATXN2 trinucleotide repeat length correlates with risk of ALSWilliam Sproviero, Aleksey Shatunov, Daniel Stahl, et al.
Pageof 4